Literature DB >> 7059989

Site-selective growth of a hormone-responsive human breast carcinoma in athymic mice.

A C White, J A Levy, C M McGrath.   

Abstract

MCF-7 is a human breast cancer line which requires estradiol supplementation for growth in s.c. tissues of athymic mice. In order to evaluate the influence of host site on hormone-dependent tumorigenicity and growth, MCF-7 cells were inoculated into tissues varying in ability to concentrate exogenous estradiol. Tumorigenicity was defined in terms of latency, threshold inoculum size, and tumor growth and progression. We observed that sites such as lung rarely supported MCF-7 tumors. However, moderately estrophilic sites such as mammary fat and adjacent subcutaneum and dermis supported the growth of small MCF-7 tumors from large tumor cell inocula, but only in estrogenized mice. In contrast, the highly estrophilic sites, brain and periuterine tissues, produced rapidly growing tumors from small tumor cell inocula. Only in periuterine tissues did tumors develop in the absence of exogenous estradiol. These studies demonstrate that tumorigenicity and growth rates of estrogen-dependent MCF-7 tumors vary as a function of tissue implantation site.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059989

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Animal modeling of human breast tumors: limitations in the use of estrogen pellet implants.

Authors:  R D Blumenthal; J J Jordan; W H McLaughlin; W D Bloomer
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

Review 2.  Endocrine therapy of human breast cancer grown in nude mice.

Authors:  N Brünner; C K Osborne; M Spang-Thomsen
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

3.  A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

Authors:  X Fu; F Guadagni; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.

Authors:  Lyndsay V Rhodes; Shannon E Muir; Steven Elliott; Lori M Guillot; James W Antoon; Patrice Penfornis; Syreeta L Tilghman; Virgilio A Salvo; Juan P Fonseca; Michelle R Lacey; Barbara S Beckman; John A McLachlan; Brian G Rowan; Radhika Pochampally; Matthew E Burow
Journal:  Breast Cancer Res Treat       Date:  2009-07-12       Impact factor: 4.872

5.  Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens.

Authors:  X Y Fu; J M Besterman; A Monosov; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 6.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

Review 7.  Considerations in the use of nude mice for cancer research.

Authors:  F E Sharkey; J Fogh
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer.

Authors:  Ehud Zigmond; Zamir Halpern; Eran Elinav; Eli Brazowski; Steffen Jung; Chen Varol
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites.

Authors:  E N Unemori; N Ways; D R Pitelka
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

10.  Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

Authors:  H J van Slooten; B A Bonsing; A J Hiller; G T Colbern; J H van Dierendonck; C J Cornelisse; H S Smith
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.